Regulation of bile acid synthesis: Pathways, nuclear receptors, and mechanisms

Journal of Hepatology

Volumn 40, Issue 3, 2004, Pages 539-551

  Chiang, John Y L ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DEXAMETHASONE; HORMONE RECEPTOR STIMULATING AGENT; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; PREGNANE X RECEPTOR; PREGNANE X RECEPTOR AGONIST; RIFAMPICIN; UNCLASSIFIED DRUG;

BILE ACID SYNTHESIS; CHOLESTASIS; DRUG METABOLISM; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER CIRRHOSIS; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 1242269851     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.11.006     Document Type: Review

References (155)

1. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 72:2003;137-174.
2. Paumgartner G. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression. J Hepatol. 39:2003;112-114.
3. Bjorkhem I. Do oxysterols control cholesterol homeostasis? J Clin Invest. 110:2002;725-730.
4. Honda A., Salen G., Matsuzaki Y., Batta A.K., Xu G., Leitersdorf E., et al. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis. J Biol Chem. 276:2001;34579-34585.
5. Lund E.G., Kerr T.A., Sakai J., Li W.P., Russell D.W. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem. 273:1998;34316-34327.
6. Duane W.C., Bjorkhem I., Hamilton J.N., Mueller S.M. Quantitative importance of the 25-hydroxylation pathway for bile acid biosynthesis in the rat. Hepatology. 8:1988;613-618.
7. Lund E.G., Guileyardo J.M., Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA. 96:1999;7238-7243.
8. Lund E.G., Xie C., Kotti T., Turley S.D., Dietschy J.M., Russell D.W. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem. 278:2003;22980-22988.
9. Li-Hawkins J., Lund E.G., Bronson A.D., Russell D.W. Expression cloning of an oxysterol 7α-hydroxylase selective for 24- hydroxycholesterol. J Biol Chem. 275:2000;16543-16549.
10. Carey M.C., Duane W.C. Arias I.M., Boyer J.L., Fausto N., Jakoby W.B., Schachter D., Shafritz D.A. The liver: biology and pathology. 1994;719-768 Raven Press, New York.
11. Hofmann A.F. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med. 159:1999;2647-2658.
12. Chiang J.Y. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev. 23:2002;443-463.
13. Chiang J.Y. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol. 284:2003;G349-G356.
14. Chiang J.Y.L., Stroup D. Identification and characterization of a putative bile acid responsive element in cholesterol 7α-hydroxylase gene promoter. J Biol Chem. 269:1994;17502-17507.
15. Chiang J.Y.L. Regulation of bile acid synthesis. Front Biosci. 3:1998;D176-D193.
16. Goodwin B., Kliewer S.A. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol. 282:2002;G926-G931.
17. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
18. Kliewer S.A., Lehmann J.M., Wilson T.M. Orphan nuclear receptors: shifting endocrinology into reverse. Science. 284:1999;757-760.
19. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science. 294:2001;1866-1870.
20. Giguere V. Orphan nuclear receptors: from gene to function. Endocr Rev. 20:1999;689-725.
21. Xie W., Evans R.M. Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem. 276:2001;37739-37742.
22. Glass C.K., Rose D.W., Rosenfeld M.G. Nuclear receptor coactivators. Curr Opin Cell Biol. 9:1997;222-232.
23. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol. 69:1999;3-12.
24. Wang H., Chen J., Hollister K., Sowers L.C., Forman B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell. 3:1999;543-553.
25. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., et al. Identification of a nuclear receptor for bile acids. Science. 284:1999;1362-1365.
26. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284:1999;1365-1368.
27. Staudinger J.L., Goodwin B., Jones S.A., Hawkins-Brown D., MacKenzie K.I., LaTour A., et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA. 98:2001;3369-3374.
28. Xie W., Radominska-Pandya A., Shi Y., Simon C.M., Nelson M.C., Ong E.S., et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA. 98:2001;3375-3380.
29. Makishima M., Lu T.T., Xie W., Whitfield G.K., Domoto H., Evans R.M., et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 296:2002;1313-1316.
30. Forman B.M., Ruan B., Chen J., Schroepfer G.J., Evans R.M. The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism. Proc Natl Acad Sci USA. 94:1997;10588-10593.
31. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA. 96:1999;266-271.
32. Song C., Hiipakka R.A., Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids. 65:2000;423-427.
33. Handschin C., Podvinec M., Amherd R., Looser R., Ourlin J.C., Meyer U.A. Cholesterol and bile acids regulate xenosensor signaling in drug- mediated induction of cytochromes P450. J Biol Chem. 277:2002;29561-29567.
34. Xanthopoulos K.G., Prezioso V.R., Chen W.S., Sladek F.M., Cortese R., Darnell J.E. The different tissue transcription patterns of genes for HNF1, C/EBP, HNF3, and HNF4 protein factors that govern liver-specific transcription. Proc Natl Acad Sci USA. 88:1991;3807-3811.
35. Hayhurst G.P., Lee Y.H., Lambert G., Ward J.M., Gonzalez F.J. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 21:2001;1393-1403.
36. Ladias J.A.A., Karathanasis S.K. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science. 251:1991;561-565.
37. Ladias J.A.A., Hadzopoulou-Cladaras M., Kardassis D., Cardot P., Cheng J., Zannis V., et al. Transcriptional regulation of human apolipoprotein genes Apo B, Apo CIII, and apo AII by member of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2 and EAR-3. J Biol Chem. 267:1992;15849-15860.
38. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 20:1999;649-688.
39. Lee C.H., Olson P., Evans R.M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. 144:2003;2201-2207.
40. Francis G.A., Fayard E., Picard F., Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol. 65:2003;261-311.
41. Stroup D., Crestani M., Chiang J.Y.L. Identification of a bile acid response element in the cholesterol 7α-hydroxylase gene (CYP7A). Am J Physiol. 273:1997;G508-G517.
42. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.-L., et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem. 272:1997;3137-3140.
43. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα Cell. 93:1998;693-704.
44. Chiang J.Y., Kimmel R., Stroup D. Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα). Gene. 262:2001;257-265.
45. Agellon L.B., Drover V.A., Cheema S.K., Gbaguidi G.F., Walsh A. Dietary cholesterol fails to stimulate the human cholesterol 7α-hydroxylase gene (CYP7A1) in transgenic mice. J Biol Chem. 277:2002;20131-20134.
46. Crestani M., Sadeghpour A., Stroup D., Gali G., Chiang J.Y.L. Transcriptional activation of the cholesterol 7α-hydroxylase gene (CYP7A) by nuclear hormone receptors. J Lipid Res. 39:1998;2192-2200.
47. Stroup D., Chiang J.Y.L. HNF4 and OUP-TFII interact to modulate transcription of the cholesterol 7α-hydroxylase gene (CYP7A). J Lipid Res. 41:2000;1-11.
48. Chiang J.Y.L., Kimmel R. Weinberger C and Stroup D, FXR responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription. J Biol Chem. 275:2000;10918-10924.
49. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 6:2000;507-515.
50. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 6:2000;517-526.
51. Nitta M., Ku S., Brown C., Okamoto A.Y., Shan B. CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene. Proc Natl Acad Sci USA. 96:1999;6660-6665.
52. Lu T.T., Repa J.J., Mangelsdorf D.J. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem. 276:2001;37735-37738.
53. Chiang J.Y.L., Miller W.F., Lin G.M. Regulation of cholesterol 7α-hydroxylase in the liver: purification of cholesterol 7α-hydroxylase and the immunochemical evidence for the induction of cholesterol 7α-hydroxylase by cholestyramine and circadian rhythm. J Biol Chem. 265:1990;3889-3897.
54. Li Y.C., Wang D.P., Chiang J.Y.L. Regulation of cholesterol 7α-hydroxylase in the liver: cDNA cloning, sequencing and regulation of cholesterol 7α-hydroxylase mRNA. J Biol Chem. 265:1990;12012-12019.
55. Noshiro M., Nishimoto M., Okuda K. Rat liver cholesterol 7α-hydroxylase. Pretranslational regulation for circadian rhythm. J Biol Chem. 265:1990;10036-10041.
56. Lavery D.J., Schibler U. Circadian transcription of the cholesterol 7α-hydroxylase gene may involve the liver-enriched bZIP protein DBP. Genes Dev. 7:1993;1871-1884.
57. Falvey E., Fleury-Olela F., Schibler U. The rat hepatic leukemia factor (HLF) gene encodes two transcriptional activators with distinct circadian rhythms, tissue distributions and target preferrences. Eur Mol Biol Org J. 14:1995;4307-4317.
58. Ogawa A., Yano M., Tsujimasa T., Morimoto T., Morita S., Taniguchi M., et al. Modulation of circadian expression of D-site binding protein by the schedule of parenteral nutrition in rat liver. Hepatology. 26:1997;1580-1586.
59. Berkowitz C.M., Shen C.S., Bilir B.M., Guibert E., Gumucio J.J. Different hepatocytes express the cholesterol 7α-hydroxylase gene during its circadian modulation in vivo. Hepatology. 21:1995;1658-1667.
60. Hara R., Wan K., Wakamatsu H., Aida R., Moriya T., Akiyama M., et al. Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus. Genes Cells. 6:2001;269-278.
61. Damiola F., Le Minh N., Preitner N., Kornmann B., Fleury-Olela F., Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 14:2000;2950-2961.
62. De Fabiani E., Mitro N., Gilardi F., Caruso D., Galli G., Crestani M. Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. J Biol Chem. 278:2003;39124-39132.
63. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 α (PGC-1 α): transcriptional coactivator and metabolic regulator. Endocr Rev. 24:2003;78-90.
64. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 413:2001;131-138.
65. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzalez F.J., et al. Regulation of hepatic fasting response by PPARγ coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4α in gluconeogenesis. Proc Natl Acad Sci USA. 100:2003;4012-4017.
66. Twisk J., Hoekman M.F.M., Lehmann E.M., Meijer P., Mager W.H., Princen H.M.G. Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7α-hydroxylase and sterol 27-hydroxylase gene transcription. Hepatology. 21:1995;501-510.
67. De Fabiani E., Crestani M., Marrapodi M., Pinelli A., Golfieri V., Galli G. Identification and characterization of cis-acting elements conferring insulin responsiveness on hamster cholesterol 7α-hydroxylase gene promoter. Biochem J. 347:2000;147-154.
68. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature. 423:2003;550-555.
69. Marrapodi M., Chiang J.Y.L. Peroxisome proliferators down-regulate the expression of the human cholesterol 7α-hydroxylase gene (CYP7A1). J Lipid Res. 41:2000;514-520.
70. Feingold K.R., Spady D.K., Pollock A.S., Moser A.H., Grunfeld C. Endotoxinand TNF IL-1 decrease cholesterol 7α-hydroxylase mRNA levels and activity. J Lipid Res. 37:1996;223-228.
71. Feingold K.R., Pollock A.S., Moser A.H., Shigenaga J.K., Grunfeld C. Discordant regulation of proteins of cholesterol metabolism during the acute phase response. J Lipid Res. 36:1995;1474-1482.
72. Ishibashi S., Schwartz M., Frykman P.K., Hertz J., Russell D.W. Disruption of cholesterol 7α-hydroxylase gene in mice: I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem. 271:1996;18017-18023.
73. Pullinger C.R., Eng C., Salen G., Shefer S., Batta A.K., Erickson S.K., et al. Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest. 110:2002;109-117.
74. Vlahcevic Z.R., Eggertsen G., Bjorkhem I., Hylemon P.B., Redford K., Pandak W.M. Regulation of sterol 12α-hydroxylase and cholic acid biosynthesis in the rat. Gastroenterology. 118:2000;599-607.
75. Ishida H., Kuruta Y., Gotoh O., Yamashita C., Yoshida Y., Noshiro M. Structure, evolution, and liver-specific expression of sterol 12α-hydroxylase P450 (CYP8B). J Biochem (Tokyo). 126:1999;19-25.
76. Hunt M.C., Yang Y.Z., Eggertsen G., Carneheim C.M., Gafvels M., Einarsson C., et al. The peroxisome proliferator-activated receptor α(PPARα) regulates bile acid biosynthesis. J Biol Chem. 275:2000;28947-28953.
77. del Castillo-Olivares A., Gil G. α1-Fetoprotein transcription factor is required for the expression of sterol 12α-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. J Biol Chem. 275:2000;17793-17799.
78. Zhang M., Chiang J.Y. Transcriptional regulation of the human sterol 12α-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4α (HNF4α) in mediating bile acid repression. J Biol Chem. 276:2001;41690-41699.
79. Yang Y., Zhang M., Eggertsen G., Chiang J.Y. On the mechanism of bile acid inhibition of rat sterol 12α- hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4α Biochim Biophys Acta. 1583:2002;63-73.
80. Li-Hawkins J., Gafvels M., Olin M., Lund E.G., Andersson U., Schuster G., et al. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest. 110:2002;1191-1200.
81. Reiss A.B., Martin K.O., Javitt N.B., Martin D.W., Grossi E.A., Galloway A.C. Sterol 27-hydroxylase: hign levels of activity in vascular endothelium. J Lipid Res. 35:1994;1026-1030.
82. Reiss A.B., Martin K.O., Rojer D.E., Iyer S., Grossi E.A., Galloway A.C., et al. Sterol 27-hydroxylase: expression in human arterial endothelium. J Lipid Res. 38:1997;1254-1260.
83. Crisby M., Nilsson J., Kostulas V., Bjorkhem I., Diczfalusy U. Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques. Biochim Biophys Acta. 1344:1997;278-285.
84. Bjorkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.-J., Duan C., et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA. 91:1994;8592-8596.
85. Zhang J., Larrson O., Sjovall J. 7α-Hydroxylation of 25-hydroxycholesterol and 27-hydroxycholesterol in human fibroblasts. Biochim Biophys Acta. 1995:1995;353-359.
86. Bjorkhem I. Mechanism of bile acid biosynthesis in mammalian liver. Danielsson H., Sjovall J. Steroid and bile acid. 1985;231-277 Elsevier, Amsterdam.
87. Bjorkhem I., Leitersdorf I. Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans. Trends Endocrinol Metab. 11:2000;180-183.
88. Oftebro H., Bjorkhem I., Skrede S., Schreiner A., Pederson J.I. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26- hydroxylation required for normal biosynthesis of cholic acid. J Clin Invest. 65:1980;1418-1430.
89. Leitersdorf E., Reshef A., Meiner V., Levitzki R., Schwartz S.P., Dann E.J., et al. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews of Moroccan origin I. Clin Invest. 91:1993;2488-2496.
90. Rosen H., Reshef A., Maeda N., Lippoldt A., Shpizen S., Triger L., et al. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27- hydroxylase gene. J Biol Chem. 273:1998;14805-14812.
91. Goodwin B., Gauthier K.C., Umetani M., Watson M.A., Lochansky M.I., Collins J.L., et al. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA. 100:2003;223-228.
92. Dussault I., Yoo H.D., Lin M., Wang E., Fan M., Batta A.K., et al. Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc Natl Acad Sci USA. 100:2003;833-838.
93. Repa J.J., Lund E.G., Horton J.D., Leitersdorf E., Russell D.W., Dietschy J.M., et al. Disruption of th sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglycridemia: Reversal by cholic acid feeding. J Biol Chem. 275:2000;39685-39692.
94. Vlahcevic Z.R., Jairath S.K., Heuman D.M., Stravitz R.T., Hylemon P.B., Avadhani N.G., et al. Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am J Physiol. 270:1996;G646-G652.
95. Xu G., Salen G., Shefer S., Tint G.S., Nguyen L.B., Parker T.T., et al. Regulation of classic and alternative bile acid synthesis in hypercholesterolemic rabbits: effects of cholesterol feeding and bile acid depletion. J Lipid Res. 39:1998;1608-1615.
96. Memon R.A., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. Potential role of hepatocyte nuclear factor-1. J Biol Chem. 276:2001;30118-30126.
97. Rose K.A., Stapleton G., Dott K., Kieny M.P., Best R., Schwarz M., et al. Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxy dehydroepiandrosterone and 7α-hydroxypregnenolone. Proc Natl Acad Sci USA. 94:1997;4925-4930.
98. Li-Hawkins J., Lund E.G., Turley S.D., Russell D.W. Disruption of the oxysterol 7alpha -hydroxylase gene in mice. J Biol Chem. 275:2000;16536-16542.
99. Rose K., Allan A., Gauldie S., Stapleton G., Dobbie L., Dott K., et al. Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation. J Biol Chem. 276:2001;23937-23944.
100. Bean R., Seckl J.R., Lathe R., Martin C. Ontogeny of the neurosteroid enzyme Cyp7b in the mouse. Mol Cell Endocrinol. 174:2001;137-144.
101. Weihua Z., Makela S., Andersson L.C., Salmi S., Saji S., Webster J.I., et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA. 98:2001;6330-6335.
102. Weihua Z., Lathe R., Warner M., Gustafsson J.A. An endocrine pathway in the prostate, ERbeta, AR, 5α-androstane-3β,17β-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA. 99:2002;13589-13594.
103. Setchell K.D.R., Schwarz M., O'Connell N.C., Lund E.G., Davis D.L., Lathe R., et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7α-hydroxylase gene causes severe neonatal liver disease. J Clin Invest. 102:1998;1690-1703.
104. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 102:2000;731-744.
105. Ananthanarayanan M., Balasubramanian N.V., Makishima M., Mangelsdorf D.J., Suchy F.J. Human bile salt export pump (BSEP) promoter is transactivated by the farnesoid X receptor/bile acid receptor (FXR/BAR). J Biol Chem. 276:2001;28857-28865.
106. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., et al. Regulation of Multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane x receptor, farnesoid x-activated receptor, and constitutive androstane receptor. J Biol Chem. 277:2002;2908-2915.
107. Yu L., Li-Hawkins J., Hammer R.E., Berge K.E., Horton J.D., Cohen J.C., et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest. 110:2002;671-680.
108. Wong M.H., Oelkers P., Craddock A.L., Dawson P.A. Expression cloning and characterization of the hamster ileal sodium- dependent bile acid transporter. J Biol Chem. 269:1994;1340-1347.
109. Grober J., Zaghini I., Fujii H., Jones S.A., Kliewer S.A., Willson T.M., et al. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid x receptor/9-cis- retinoic acid receptor heterodimer. J Biol Chem. 274:1999;29749-29754.
110. Denson L.A., Sturm E., Echevarria W., Zimmerman T.L., Makishima M., Mangelsdorf D.J., et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology. 121:2001;140-147.
111. Urizar N.L., Moore D.D. A gugulipid: natural cholesterol-lowering agent. Annu Rev Nutr. 2003.
112. Urizar N.L., Liverman A.B., Dodds D.T., Silva F.V., Ordentlich P., Yan Y., et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 296:2002;1703-1706.
113. Cui J., Huang L., Zhao A., Lew J.L., Yu J., Sahoo S., et al. Guggulsterone is an FXR antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. J Biol Chem. 278:2003;10214-10220.
114. Owsley E., Chiang J.Y. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7α-hydroxylase gene. Biochem Biophys Res Commun. 304:2003;191-195.
115. Wu J., Xia C., Meier J., Li S., Hu X., Lala D.S. The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Mol Endocrinol. 16:2002;1590-1597.
116. Dussault I., Beard R., Lin M., Hollister K., Chen J., Xiao J.H., et al. Identification of gene-selective modulators of the bile acid receptor FXR. J Biol Chem. 2002.
117. Urizar N.L., Dowhan D.H., Moore D.D. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem. 275:2000;39313-39317.
118. Cao G., Beyer T.P., Yang X.P., Schmidt R.J., Zhang Y., Bensch W.R., et al. Phospholipid transfer protein is regulated by liver X receptors in vivo. J Biol Chem. 277:2002;39561-39565.
119. Kast H.R., Nguyen C.M., Sinal C.J., Jones S.A., Laffitte B.A., Reue K., et al. Farnesoid x-activated receptor induces apolipoprotein c-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol. 15:2001;1720-1728.
120. Mak P.A., Kast-Woelbern H.R., Anisfeld A.M., Edwards P.A. Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors. J Lipid Res. 43:2002;2037-2041.
121. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA. 98:2001;507-512.
122. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA. 97:2000;12097-12102.
123. Zhang Y., Repa J.J., Gauthier K., Mangelsdorf D.J. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem. 276:2001;43018-43024.
124. Luo Y., Tall A.R. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest. 276:2000;24767-24773.
125. Lambert G., Amar M.J., Guo G., Brewer H.B. Jr, Gonzalez F.J., Sinal C.J. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem. 278:2003;2563-2570.
126. Claudel T., Sturm E., Duez H., Torra I.P., Sirvent A., Kosykh V., et al. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest. 109:2002;961-971.
127. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem. 275:2000;28240-28245.
128. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 22:1999;347-351.
129. Mak P.A., Laffitte B.A., Desrumaux C., Joseph S.B., Curtiss L.K., Mangelsdorf D.J., et al. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J Biol Chem. 277:2002;31900-31908.
130. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell. 7:2001;161-171.
131. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 289:2000;1524-1529.
132. Plosch T., Kok T., Bloks V.W., Smit M.J., Havinga R., Chimini G., et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem. 277:2002;33870-33877.
133. Lee M.H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet. 27:2001;79-83.
134. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290:2000;1771-1775.
135. Tontonoz P., Mangelsdorf D.J. Liver x receptor signaling pathways in cardiovascular disease. Mol Endocrinol. 17:2003;985-993.
136. Maloney P.R., Parks D.J., Haffner C.D., Fivush A.M., Chandra G., Plunket K.D., et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem. 43:2000;2971-2974.
137. Claudel T., Inoue Y., Barbier O., Duran-Sandoval D., Kosykh V., Fruchart J., et al. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology. 125:2003;544-555.
138. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.C., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294:2001;169-173.
139. Prieur X., Coste H., Rodriguez J.C. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor α and contains a novel farnesoid X-activated receptor response element. J Biol Chem. 278:2003;25468-25480.
140. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ Genes Dev. 14:2000;2819-2830.
141. Lund E.G., Menke J.G., Sparrow C.P. Liver x receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol. 23:2003;1169-1177.
142. Einarsson K., Gustafsson J.A. Effects of a potent catatoxic steroid, 16 -cyanopregnenolone, on microsomal metabolism of steroid hormones, sterols and bile acids in rats. Eur J Biochem. 32:1973;197-206.
143. Einarsson K., Gustafsson J.A. Effect of 16α-cyanopregnenolone on the hydroxylation of lithocholic acid by rat liver microsomes. Biochem Pharmacol. 23:1974;9-12.
144. Hofmann A.F. Rifampicin and treatment of cholestatic pruritus. Gut. 51:2002;756-757.
145. Prince M.I., Burt A.D., Jones D.E. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut. 50:2002;436-439.
146. Laffitte B.A., Chao L.C., Li J., Walczak R., Hummasti S., Joseph S.B., et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA. 100:2003;5419-5424.
147. Wang L., Lee Y.K., Bundman D., Han Y., Thevananther S., Kim C.S., et al. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell. 2:2002;721-731.
148. Kerr T.A., Saeki S., Schneider M., Schaefer K., Berdy S., Redder T., et al. Loss of nuclear receptor shp impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell. 2:2002;713-720.
149. Stravitz R.T., Vlahcevic Z.R., Gurley E.C., Hylemons P.B. Repression of cholesterol 7α-hydroxylase transcription by bile acids is mediated through protein kinase C in primary cultures of rat hepatocytes. J Lipid Res. 36:1995;1359-1368.
150. Stravitz R.T., Rao Y.P., Vlahcevic Z.R., Gurley E.C., Jarvis W.D., Hylemon P.B. Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7α-hydroxylase. Am J Physiol. 34:1996;G293-G303.
151. Miyake J.H., Wang S.L., Davis R.A. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7α-hydroxylase. J Biol Chem. 275:2000;21805-21808.
152. De Fabiani E., Mitro N., Anzulovich A.C., Pinelli A., Galli G., Crestani M. The negative effects of bile acids and tumor necrosis factorα on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4. A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem. 276:2001;30708-30716.
153. Soutoglou E., Katrakili N., Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell. 5:2000;745-751.
154. Soutoglou E., Talianidis I. Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science. 295:2002;1901-1904.
155. Holt J.A., Luo G., Billin A.N., Bisi J., McNeill Y.Y., Kozarsky K.F., et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17:2003;1581-1591.